Insilico Medicine Added to Hang Seng Biotech Index, Effective 8 June 2026

Bulletin Express

05/26

Insilico Medicine Cayman TopCo (Insilico Medicine) announced that Hang Seng Indexes Company Limited will include the company as a constituent of the Hang Seng Biotech Index following its first-quarter 2026 review. The adjustment will be implemented after market close on 5 June 2026 and take effect on 8 June 2026.

The Hang Seng Biotech Index tracks the performance of the 30 largest biotech companies listed in Hong Kong that are eligible for Southbound Stock Connect trading. Insilico Medicine’s inclusion signals growing market recognition of its long-term growth prospects and is expected to broaden exposure to index-tracking and institutional portfolios, potentially enhancing share liquidity and investor diversification.

The Board expressed appreciation for shareholder support and reiterated that forward-looking statements are subject to uncertainties. Shareholders and potential investors are advised to exercise caution when dealing in the company’s shares. The announcement was dated 26 May 2026 and signed by Chairman, Executive Director, CEO and CBO, Dr. Aleksandrs Zavoronkovs.

免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。

热议股票

1
2
3
4
5
6
7
8
9
10

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.itiger.com/hans/news/1176084051"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1176084051\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1176084051?lang=zh_CN&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-05-26 17:03","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1176084051","market":"us","top_or_hot":-1,"title":"Insilico Medicine Added to Hang Seng Biotech Index, Effective 8 June 2026","media":"Bulletin Express","content":"<p>Insilico Medicine Cayman TopCo (Insilico Medicine) announced that Hang Seng Indexes Company Limited will include the company as a constituent of the Hang Seng Biotech Index following its first-quarter 2026 review. The adjustment will be implemented after market close on 5 June 2026 and take effect on 8 June 2026.</p>\n<p>The Hang Seng Biotech Index tracks the performance of the 30 largest biotech companies listed in Hong Kong that are eligible for Southbound Stock Connect trading. Insilico Medicine’s inclusion signals growing market recognition of its long-term growth prospects and is expected to broaden exposure to index-tracking and institutional portfolios, potentially enhancing share liquidity and investor diversification.</p>\n<p>The Board expressed appreciation for shareholder support and reiterated that forward-looking statements are subject to uncertainties. Shareholders and potential investors are advised to exercise caution when dealing in the company’s shares. The announcement was dated 26 May 2026 and signed by Chairman, Executive Director, CEO and CBO, Dr. Aleksandrs Zavoronkovs.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Insilico Medicine Added to Hang Seng Biotech Index, Effective 8 June 2026</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nInsilico Medicine Added to Hang Seng Biotech Index, Effective 8 June 2026\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1053168898\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Bulletin Express </p>\n<p class=\"h-time\">2026-05-26 17:03</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Insilico Medicine Cayman TopCo (Insilico Medicine) announced that Hang Seng Indexes Company Limited will include the company as a constituent of the Hang Seng Biotech Index following its first-quarter 2026 review. The adjustment will be implemented after market close on 5 June 2026 and take effect on 8 June 2026.</p>\n<p>The Hang Seng Biotech Index tracks the performance of the 30 largest biotech companies listed in Hong Kong that are eligible for Southbound Stock Connect trading. Insilico Medicine’s inclusion signals growing market recognition of its long-term growth prospects and is expected to broaden exposure to index-tracking and institutional portfolios, potentially enhancing share liquidity and investor diversification.</p>\n<p>The Board expressed appreciation for shareholder support and reiterated that forward-looking statements are subject to uncertainties. Shareholders and potential investors are advised to exercise caution when dealing in the company’s shares. The announcement was dated 26 May 2026 and signed by Chairman, Executive Director, CEO and CBO, Dr. Aleksandrs Zavoronkovs.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"03696","symbol_name":"英矽智能","start_time":0,"source_url":"","article_id":"1176084051","we_media_id":"1053168898","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1176084051","pubTimestamp":1779786212,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Bulletin Express","introduction":"Full Coverage of HK & US Stock Announcements","home_visible":1,"id":"1053168898","head_image":"https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e"},"summary":"Insilico Medicine Cayman TopCo (Insilico Medicine) announced that Hang Seng Indexes Company Limited will include the company as a constituent of the Hang Seng Biotech Index following its...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"03696":"英矽智能"},"translate_title":"英矽智能加入恒生生物科技指数，自2026年6月8日起生效","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"03696":1},"content_text":"Insilico Medicine Cayman TopCo (Insilico Medicine) announced that Hang Seng Indexes Company Limited will include the company as a constituent of the Hang Seng Biotech Index following its first-quarter 2026 review. The adjustment will be implemented after market close on 5 June 2026 and take effect on 8 June 2026.\nThe Hang Seng Biotech Index tracks the performance of the 30 largest biotech companies listed in Hong Kong that are eligible for Southbound Stock Connect trading. Insilico Medicine’s inclusion signals growing market recognition of its long-term growth prospects and is expected to broaden exposure to index-tracking and institutional portfolios, potentially enhancing share liquidity and investor diversification.\nThe Board expressed appreciation for shareholder support and reiterated that forward-looking statements are subject to uncertainties. Shareholders and potential investors are advised to exercise caution when dealing in the company’s shares. The announcement was dated 26 May 2026 and signed by Chairman, Executive Director, CEO and CBO, Dr. Aleksandrs Zavoronkovs.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"1","news_tag":"executive,SGX","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"}}}